Latest News
Latest News
Date Subject Media
2025-09-18 UTHR’s Nebulized Tyvaso Achieves Success in Expanding to Third Indication, PHARMOSA BIOPHARM’s L606 Poised to Benefit Investor
2025-09-18 Advanced Connection Technology Expands into Biomedical Cell Testing, Plans to Develop Exosome-Based Cancer Screening MoneyDJ
2025-09-18 BRIM Biotechnology Invests NT$150 Million in Compass Bioinformatics to Seize Precision Medicine Opportunities Commercial Times
2025-09-18 Maywufa Group Joint Investor Conference Highlights Diverse Growth Driven by Consumer Products, New Drugs, and Smart Healthcare Economic Daily News
2025-09-18 Alar Pharmaceuticals Advances Multiple Pipeline Programs; Pet Osteoarthritis Study and Treatment-Resistant Depression Phase 1 Trial Target Year-End Completion Investor
2025-09-18 Panion & BF Biotech Expands Capacity with New Plant; Advances Novel Formulation Drug Pipeline MoneyDJ
2025-09-18 Ever Supreme Bio Technology Posts Record August Revenue; Eight-Month Revenue Up 14.3% Year-on-Year Commercial Times
2025-09-18 Enimmune’s Enterovirus Vaccine Approved for Process Scale-Up, Strengthening Southeast Asia Market Entry Investor
2025-09-18 VIZIONFOCUS’ Multi-Market Expansion Drives H2 Revenue Growth, Full-Year Increase Projected at 10–15% Investor
2025-09-18 OBI Pharma Executes 50% Capital Reduction to Offset Losses, Focuses Future on ADC Development Economic Daily News
431-440 of 920  Page
Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.
© 2026 Institute for Biotechnology and Medicine Industry (IBMI) All rights reserved.
Address:9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number:(02)2655-8168 Fax:(02)2655-7978